BridgeBio team clears a key hurdle with their proof-of-concept data for a rare genetic disease. And they can thank the NIH for a quick success

BridgeBio’s Calcilytix team has several good reasons to offer some special thanks to the NIH today.

Mike Collins, an NIH researcher and division chief who …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bridge­Bio team clears a key hur­dle with their proof-of-con­cept da­ta for a rare ge­net­ic dis­ease. And they can thank the NIH for a quick suc­cess